
    
      This study is a prospective, double blind, randomized clinical trial. Vaginal health
      screening and HPV DNA Test are carried out from 80 patients with positive HPV DNA Test after
      conization for 6 months. All these patients will participant this study during the 360-day
      trial period. All health related conditions will be monitored at the same time.
    
  